|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Heffernan Michael Thomas
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-06-17 Sale |
2019-06-19 6:05 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
25,000 | $11.37 | $284,246 | 159,090 (Direct) |
View |
| 2019-05-15 Sale |
2019-05-17 4:04 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
25,000 | $12.84 | $321,042 | 188,586 (Direct) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:01 pm |
Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director |
2,500 | $10 | $25,000 | 6,351 (Direct) |
View |
| 2019-04-15 Sale |
2019-04-17 4:24 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
25,000 | $15.09 | $377,366 | 207,170 (Direct) |
View |
| 2019-03-15 Sale |
2019-03-19 5:36 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
25,000 | $17.17 | $429,250 | 227,362 (Direct) |
View |
| 2019-02-15 Sale |
2019-02-20 4:17 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
25,000 | $14.81 | $370,224 | 259,430 (Direct) |
View |
| 2019-01-15 Sale |
2019-01-17 4:16 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
25,000 | $15.56 | $389,000 | 286,000 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-18 5:09 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
25,000 | $18.18 | $454,491 | 314,313 (Direct) |
View |
| 2018-11-15 Sale |
2018-11-16 4:19 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
25,000 | $16.6 | $415,122 | 339,600 (Direct) |
View |
| 2018-10-15 Sale |
2018-10-17 4:27 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
25,000 | $16.53 | $413,250 | 361,000 (Direct) |
View |
| 2018-06-11 Sale |
2018-06-13 4:56 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman |
150,000 | $25.27 | $3,790,939 | 441,750 (Direct) |
View |
| 2018-05-10 Sale |
2018-05-14 4:32 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman |
7,100 | $26.21 | $186,100 | 540,193 (Direct) |
View |
| 2018-04-19 Sale |
2018-04-23 5:05 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman |
44,400 | $26 | $1,154,401 | 545,893 (Direct) |
View |
| 2018-01-22 Sale |
2018-01-23 5:41 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman |
3,592 | $25 | $89,800 | 535,395 (Direct) |
View |
| 2018-01-19 Sale |
2018-01-19 5:41 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman |
20,000 | $22.5 | $450,000 | 538,987 (Direct) |
View |
| 2017-11-15 Sale |
2017-11-17 9:04 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman |
50,000 | $15.53 | $776,500 | 558,987 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-06-06 Option Award |
2019-06-10 4:04 pm |
N/A N/A |
Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director |
13,700 | $0 | 21,186 (Direct) |
View |
| 2019-06-06 Option Award |
2019-06-10 4:04 pm |
2020-06-06 2029-06-06 |
Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director |
20,100 | $4.23 | 21,186 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:01 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director |
3,851 | $0 | 6,351 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:01 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director |
34,247 | $0 | 6,351 (Direct) |
View |
| 2019-05-07 Option Award |
2019-05-08 5:01 pm |
N/A 2029-05-06 |
Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director |
23,684 | $10 | 23,684 (Direct) |
View |
| 2019-04-25 Option Award |
2019-04-30 08:52 am |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
4,707 | $0 | 207,069 (Direct) |
View |
| 2019-04-25 Option Award |
2019-04-30 08:52 am |
N/A 2029-04-25 |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
9,414 | $14.57 | 207,069 (Direct) |
View |
| 2019-02-08 Tax Withholding |
2019-02-11 5:06 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
7,851 | $14.39 | 277,362 (Direct) |
View |
| 2019-01-18 Tax Withholding |
2019-01-23 4:14 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
787 | $15.76 | 285,213 (Direct) |
View |
| 2018-12-12 Option Award |
2018-12-13 6:38 pm |
N/A N/A |
Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director |
7,486 | $0 | 25,000 (Direct) |
View |
| 2018-12-12 Option Award |
2018-12-13 6:38 pm |
N/A 2026-06-21 |
Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director |
18,716 | $16.17 | 25,000 (Direct) |
View |
| 2018-12-12 Option Award |
2018-12-13 6:38 pm |
N/A 2027-06-09 |
Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director |
11,229 | $17.53 | 25,000 (Direct) |
View |
| 2018-12-12 Option Award |
2018-12-13 6:38 pm |
N/A 2028-06-30 |
Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director |
11,229 | $10.05 | 25,000 (Direct) |
View |
| 2018-12-12 Option Award |
2018-12-13 6:38 pm |
N/A 2028-12-12 |
Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director |
25,000 | $8.94 | 25,000 (Direct) |
View |
| 2018-12-12 Disposition |
2018-12-13 4:35 pm |
N/A N/A |
KERYX BIOPHARMACEUTICALS INC | KERX | Heffernan Michael Thomas Director |
20,000 | $0 | 0 (Direct) |
View |
| 2018-12-12 Disposition |
2018-12-13 4:35 pm |
N/A N/A |
KERYX BIOPHARMACEUTICALS INC | KERX | Heffernan Michael Thomas Director |
110,000 | $0 | 0 (Direct) |
View |
| 2018-08-23 Tax Withholding |
2018-08-27 4:06 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
2,025 | $18.03 | 386,000 (Direct) |
View |
| 2018-08-03 Tax Withholding |
2018-08-06 5:41 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
668 | $20.15 | 388,025 (Direct) |
View |
| 2018-06-30 Option Award |
2018-07-12 5:59 pm |
N/A N/A |
KERYX BIOPHARMACEUTICALS INC | KERX | Heffernan Michael Thomas Director |
10,000 | $0 | 30,000 (Direct) |
View |
| 2018-06-30 Option Award |
2018-07-12 5:59 pm |
2019-06-30 2028-06-30 |
KERYX BIOPHARMACEUTICALS INC | KERX | Heffernan Michael Thomas Director |
30,000 | $3.76 | 30,000 (Direct) |
View |
| 2018-02-26 Tax Withholding |
2018-03-01 4:04 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman |
4,050 | $21.77 | 590,193 (Direct) |
View |
| 2018-02-05 Tax Withholding |
2018-02-06 4:14 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman |
788 | $23.38 | 594,243 (Direct) |
View |
| 2018-01-25 Option Award |
2018-01-29 7:41 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman |
75,000 | $0 | 595,031 (Direct) |
View |
| 2018-01-25 Option Award |
2018-01-29 7:41 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman |
1,044 | $10.17 | 595,031 (Direct) |
View |
| 2018-01-25 Option Award |
2018-01-29 7:41 pm |
N/A 2028-01-25 |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman |
150,000 | $24.35 | 595,031 (Direct) |
View |
| 2018-01-22 Sale |
2018-01-23 5:41 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman |
16,408 | $25.01 | 535,395 (Direct) |
View |
| 2017-08-04 Option Award |
2017-08-04 4:17 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman |
640 | $10.6 | 609,723 (Direct) |
View |
| 2017-08-04 Tax Withholding |
2017-08-04 4:17 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman |
736 | $12.39 | 609,723 (Direct) |
View |
| 2017-06-09 Option Award |
2017-06-20 4:12 pm |
N/A N/A |
KERYX BIOPHARMACEUTICALS INC | KERX | Heffernan Michael Thomas Director |
10,000 | $0 | 30,000 (Direct) |
View |
| 2017-06-09 Option Award |
2017-06-20 4:12 pm |
2018-06-09 2027-06-09 |
KERYX BIOPHARMACEUTICALS INC | KERX | Heffernan Michael Thomas Director |
30,000 | $6.56 | 30,000 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Thu, 20 Jun 2019 10:50:14 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |